omeprazole has been researched along with Adenocarcinoma in 62 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 158 patients (155 early gastric cancers and three adenomas) were randomly assigned to the PPI group (omeprazole 20 mg/day) or H(2) RA group (famotidine 40 mg/day) in a prospective randomized controlled trial." | 5.16 | Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection. ( Fukui, H; Hori, K; Kim, Y; Kondo, T; Matsumoto, T; Miwa, H; Morita, T; Okugawa, T; Oshima, T; Sakurai, J; Tanaka, J; Tomita, T; Toyoshima, F; Watari, J; Yamasaki, T, 2012) |
| " pylori infection, indomethacin and their combination affects the healing of gastric ulcers and whether or not such factors provoke a relapse of healed acetic acid ulcers; and 2) whether or not eradication of the bacteria with drugs at specified times after infection prevents the development of mucosal changes, including gastric adenocarcinoma." | 4.81 | [Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils]. ( Ebata, M; Keto, Y; Okabe, S, 2001) |
| "In our study, oral administration of omeprazole for 1 week was sufficient to achieve healing of ESD-induced artificial gastric ulcers." | 3.81 | Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study. ( Ando, T; Fujinami, H; Hosokawa, A; Kajiura, S; Mihara, H; Minemura, M; Nishikawa, J; Ogawa, K; Sugiyama, T; Ueda, A, 2015) |
| "Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) have been associated with some drugs, particularly anticonvulsants such as phenytoin." | 3.74 | [Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy]. ( Fernández, FA; Garcés, FJ; Pintor, E; Quesada, R, 2007) |
| "We pretreated cell lines derived from human melanomas, adenocarcinomas, and lymphomas with the PPIs omeprazole, esomeprazole, or pantoprazole and tested their response to cytotoxic drugs in cell death assays." | 3.72 | Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. ( Arancia, G; Belardelli, F; De Milito, A; Fais, S; Federici, C; Iessi, E; Logozzi, M; Lozupone, F; Luciani, F; Lugini, L; Marra, M; Molinari, A; Montinaro, A; Parmiani, G; Rivoltini, L; Spada, M, 2004) |
| "The case of an intramucosal adenocarcinoma diagnosed 18 months after apparently complete squamous re-epithelialisation achieved using argon plasma coagulation and high dose omeprazole (40 mg/daily) is reported in a 68 year old patient presenting initially with a Barrett's oesophagus without dysplasia." | 3.70 | Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. ( Cremer, M; Devière, J; Peny, MO; Salmon, I; Van Laethem, JL, 2000) |
| " In this case report, a patient with Barrett's oesophagus complicated by high grade dysplasia and focal adenocarcinoma was treated by Nd:Yag laser then high dose rate intraluminal irradiation while on omeprazole 40 mg/day." | 3.69 | [Partial regression of Barret esophagus with high grade dysplasia and adenocarcinoma after photocoagulation and endocurietherapy under antisecretory treatment]. ( Bouché, O; Demange, L; Diébold, MD; Fremond, L; Thiefin, G; Zeitoun, P, 1995) |
| "pylori decreases gastric cancer risk, using preneoplastic conditions as surrogate markers." | 2.71 | Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. ( Figueroa, LS; Guarner, J; Halperin, D; Herrera-Goepfert, R; Johnstone, I; Ley, C; Mohar, A; Parsonnet, J, 2004) |
| "pylori at 6 wk were infected at 1 yr (recurrence rates 10." | 2.70 | Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure. ( Figueroa, LS; Guarner, J; Halperin, D; Herrera-Goepfert, R; Ley, C; Mohar, A; Parsonnet, J, 2002) |
| "KTP laser destruction of Barrett's esophagus induced mucosal regeneration with normal squamous cell epithelium in combination with acid suppression." | 2.69 | KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. ( Ell, C; Gossner, L; Hahn, EG; May, A; Seitz, G; Stolte, M, 1999) |
| "Typical GERD symptoms are often sufficient to determine the diagnosis, but less common symptoms and signs, such as dysphagia and chronic cough, may occur." | 2.66 | Gastroesophageal Reflux Disease: A Review. ( Lagergren, J; Maret-Ouda, J; Markar, SR, 2020) |
| "The treatment of Barrett's esophagus is controversial." | 2.43 | [The clinical strategy for the Barrett's esophagus]. ( Goto, H; Kitabatake, S; Niwa, Y, 2005) |
| " Methods to optimize nocturnal acid control include careful attention to dosing schedule, using higher doses of PPIs, adding an histamine H2-receptor antagonist at bedtime to once or twice daily delayed-release PPI, or using immediate-release omeprazole (Zegerid powder for oral suspension; Santarus, Inc." | 2.43 | Review article: putting immediate-release proton-pump inhibitors into clinical practice--improving nocturnal acid control and avoiding the possible complications of excessive acid exposure. ( Katz, PO, 2005) |
| "The key feature of GERD is reflux of gastric contents into the esophagus." | 2.42 | Reflux disease and Barrett's esophagus. ( Haag, S; Holtmann, G, 2003) |
| "He was also diagnosed to have gastric cancer with Helicobacter pylori infection." | 2.42 | Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy. ( Arima, N; Tsudo, M, 2003) |
| " Instances in which laparoscopic Nissen fundoplication should be considered include: 1) Individuals who are intolerant of proton pump inhibitor therapy because of side effects, 2) When patients are inadequately responsive to proton pump inhibitor therapy even after dosage and dose interval have been optimized, and 3) When a patient desires a permanent solution to their reflux problem that frees them of the need to chronically consume pharmaceuticals." | 2.41 | Management of GERD: medical versus surgical. ( Kahrilas, PJ, 2001) |
| "Short-segment Barrett's esophagus is now clearly associated with an increased risk of dysplasia or cancer compared to intestinal metaplasia of the cardia, and the cancer risk in this condition is similar to that with long-segment Barrett's esophagus." | 2.41 | Gastroesophageal reflux disease and Barrett's esophagus. ( Falk, GW, 2001) |
| "36), we did not find a dose-response relationship with PPI duration (P trend = 0." | 1.48 | Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans. ( El-Serag, HB; Tan, MC; Thrift, AP; Yu, X, 2018) |
| "Esophageal squamous cell carcinoma developed in INK4a/Arf+/- mice (7." | 1.35 | Gastroesophageal reflux leads to esophageal cancer in a surgical model with mice. ( Chen, X; Hao, J; Liu, B; Yang, CS, 2009) |
| "Duodenogastric reflux is known to cause an increased frequency of cancer in the glandular portion of the stomach in rats." | 1.32 | Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux. ( Maartmann-Moe, H; Viste, A; Waldum, H; Øvrebø, K, 2004) |
| "Strategies to prevent Barrett's-related esophageal cancer have focused on reversal of Barrett's using pharmacological or surgical antireflux therapies and endoscopically-induced injury." | 1.31 | Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression? ( Fennerty, MB, 2002) |
| "Duodenoesophageal reflux was induced in 60 rats by performing a duodenesophagostomy." | 1.31 | Adenocarcinoma of the rat esophagus in the presence of a proton pump inhibitor: a pilot study. ( Barry, P; Burn, J; Falk, G; Moore, KH, 2001) |
| "Cytology from Barrett's esophagus can be misleading in the presence of severe inflammation." | 1.30 | Brush cytology in the diagnosis of neoplasia in Barrett's esophagus. ( Alderson, D; Hardwick, RH; Lott, M; Morgan, RJ; Warren, BF, 1997) |
| "Endoscopic ablation of Barrett's esophagus, including associated dysplasia and adenocarcinoma, can be achieved by various techniques, but few long-term results are available." | 1.30 | Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up. ( Bhattacharyya, A; Jaffe, PE; Sampliner, RE; Sharma, P, 1999) |
| "None of the rats developed esophageal cancer, but esophageal mucosal hyperplasia was more pronounced in rats receiving omeprazole." | 1.30 | Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux. ( Adrian, TE; Hinder, RA; Perdikis, G; Profanter, C; Smyrk, T; Wetscher, GJ, 1999) |
| "Thirty-six patients with Barrett's esophagus and dysplasia were treated with photodynamic therapy, and sodium porfimer 2." | 1.29 | Photodynamic therapy for Barrett's esophagus: clinical update. ( Overholt, BF; Panjehpour, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.61) | 18.7374 |
| 1990's | 17 (27.42) | 18.2507 |
| 2000's | 31 (50.00) | 29.6817 |
| 2010's | 8 (12.90) | 24.3611 |
| 2020's | 5 (8.06) | 2.80 |
| Authors | Studies |
|---|---|
| Szachnowicz, S | 1 |
| Duarte, AF | 1 |
| Nasi, A | 1 |
| da Rocha, JRM | 1 |
| Seguro, FB | 1 |
| Bianchi, ET | 1 |
| Tustumi, F | 1 |
| de Moura, EGH | 1 |
| Sallum, RAA | 1 |
| Cecconello, I | 1 |
| Monteiro, RLR | 1 |
| Kobayasi, MAMR | 1 |
| Araujo, MR | 1 |
| Monteiro, DR | 1 |
| Andreollo, NA | 1 |
| Maret-Ouda, J | 1 |
| Markar, SR | 1 |
| Lagergren, J | 1 |
| Howden, CW | 1 |
| Graham, DY | 1 |
| Madka, V | 1 |
| Kumar, G | 1 |
| Pathuri, G | 1 |
| Panneerselvam, J | 1 |
| Zhang, Y | 1 |
| Ganta, V | 1 |
| Lightfoot, S | 1 |
| Lubet, R | 1 |
| Suen, CS | 1 |
| Steele, VE | 1 |
| Janakiram, NB | 1 |
| Mohammed, A | 1 |
| Rao, CV | 1 |
| Tan, MC | 1 |
| El-Serag, HB | 1 |
| Yu, X | 1 |
| Thrift, AP | 1 |
| Huang, J | 1 |
| Liu, H | 1 |
| Sun, T | 1 |
| Fang, JY | 1 |
| Wang, J | 1 |
| Xiong, H | 1 |
| Kajiura, S | 1 |
| Hosokawa, A | 1 |
| Ueda, A | 1 |
| Mihara, H | 1 |
| Ando, T | 1 |
| Fujinami, H | 1 |
| Nishikawa, J | 1 |
| Ogawa, K | 2 |
| Minemura, M | 1 |
| Sugiyama, T | 1 |
| Sundaresan, S | 1 |
| Kang, AJ | 1 |
| Hayes, MM | 1 |
| Choi, EK | 1 |
| Merchant, JL | 1 |
| Hao, J | 2 |
| Zhang, B | 1 |
| Liu, B | 2 |
| Lee, M | 1 |
| Hao, X | 1 |
| Reuhl, KR | 1 |
| Chen, X | 2 |
| Yang, CS | 2 |
| Sharma, P | 2 |
| Triadafilopoulos, G | 1 |
| Lombard, CM | 1 |
| Jobe, BA | 1 |
| Lord, RV | 1 |
| Tomita, T | 1 |
| Kim, Y | 1 |
| Yamasaki, T | 1 |
| Okugawa, T | 1 |
| Kondo, T | 1 |
| Toyoshima, F | 1 |
| Sakurai, J | 1 |
| Tanaka, J | 1 |
| Morita, T | 1 |
| Oshima, T | 1 |
| Fukui, H | 1 |
| Hori, K | 1 |
| Watari, J | 1 |
| Matsumoto, T | 1 |
| Miwa, H | 1 |
| Miyashita, T | 1 |
| Shah, FA | 1 |
| Harmon, JW | 1 |
| Marti, GP | 1 |
| Matsui, D | 1 |
| Okamoto, K | 1 |
| Makino, I | 1 |
| Hayashi, H | 1 |
| Oyama, K | 1 |
| Nakagawara, H | 1 |
| Tajima, H | 1 |
| Fujita, H | 1 |
| Takamura, H | 1 |
| Murakami, M | 1 |
| Ninomiya, I | 1 |
| Kitagawa, H | 1 |
| Fushida, S | 1 |
| Fujimura, T | 1 |
| Ohta, T | 1 |
| Watson, SA | 1 |
| Morris, TM | 1 |
| McWilliams, DF | 1 |
| Harris, J | 1 |
| Evans, S | 1 |
| Smith, A | 1 |
| Clarke, PA | 1 |
| Mohar, A | 2 |
| Ley, C | 2 |
| Guarner, J | 2 |
| Herrera-Goepfert, R | 2 |
| Figueroa, LS | 2 |
| Halperin, D | 2 |
| Parsonnet, J | 2 |
| Barr, H | 2 |
| Fennerty, MB | 1 |
| Haag, S | 1 |
| Holtmann, G | 1 |
| Arima, N | 1 |
| Tsudo, M | 1 |
| Parrilla, P | 1 |
| Martínez de Haro, LF | 1 |
| Ortiz, A | 1 |
| Munitiz, V | 1 |
| Molina, J | 1 |
| Bermejo, J | 1 |
| Canteras, M | 1 |
| Vakil, N | 1 |
| Overholt, BF | 5 |
| Panjehpour, M | 4 |
| Halberg, DL | 1 |
| Johnstone, I | 1 |
| Hamaguchi, K | 1 |
| Katsube, T | 1 |
| Konno, S | 1 |
| Aiba, M | 1 |
| Viste, A | 1 |
| Øvrebø, K | 1 |
| Maartmann-Moe, H | 1 |
| Waldum, H | 1 |
| Jankowski, J | 1 |
| Moayyedi, P | 1 |
| Luciani, F | 1 |
| Spada, M | 1 |
| De Milito, A | 1 |
| Molinari, A | 1 |
| Rivoltini, L | 1 |
| Montinaro, A | 1 |
| Marra, M | 1 |
| Lugini, L | 1 |
| Logozzi, M | 1 |
| Lozupone, F | 1 |
| Federici, C | 1 |
| Iessi, E | 1 |
| Parmiani, G | 1 |
| Arancia, G | 1 |
| Belardelli, F | 1 |
| Fais, S | 1 |
| Tanabe, H | 1 |
| Hara, H | 1 |
| Ohtubo, C | 1 |
| Miyokawa, N | 1 |
| Sano, H | 1 |
| Kitabatake, S | 1 |
| Niwa, Y | 1 |
| Goto, H | 1 |
| Katz, PO | 1 |
| Cooper, BT | 1 |
| Chapman, W | 1 |
| Neumann, CS | 1 |
| Gearty, JC | 1 |
| Wang, KK | 1 |
| Burdick, JS | 1 |
| Lightdale, CJ | 1 |
| Kimmey, M | 1 |
| Nava, HR | 1 |
| Sivak, MV | 1 |
| Nishioka, N | 1 |
| Marcon, N | 1 |
| Pedrosa, M | 1 |
| Bronner, MP | 1 |
| Grace, M | 1 |
| Depot, M | 1 |
| Fernández, FA | 1 |
| Pintor, E | 1 |
| Quesada, R | 1 |
| Garcés, FJ | 1 |
| Lönnroth, C | 1 |
| Andersson, M | 1 |
| Arvidsson, A | 1 |
| Nordgren, S | 1 |
| Brevinge, H | 1 |
| Lagerstedt, K | 1 |
| Lundholm, K | 1 |
| Fremond, L | 1 |
| Bouché, O | 1 |
| Diébold, MD | 1 |
| Demange, L | 1 |
| Zeitoun, P | 1 |
| Thiefin, G | 1 |
| Waldum, HL | 1 |
| Brenna, E | 1 |
| Hassall, E | 1 |
| Ertan, A | 1 |
| Zimmerman, M | 1 |
| Younes, M | 1 |
| Matsunaga, K | 1 |
| Oofukuji, M | 1 |
| Syukuwa, S | 1 |
| Osabe, M | 1 |
| Takeno, Y | 1 |
| Isomoto, H | 1 |
| Mizuta, Y | 1 |
| Kohno, S | 1 |
| Hardwick, RH | 1 |
| Morgan, RJ | 1 |
| Warren, BF | 1 |
| Lott, M | 1 |
| Alderson, D | 1 |
| Wayman, J | 1 |
| Hayes, N | 1 |
| Griffin, SM | 1 |
| Chen, D | 1 |
| Destrée, M | 1 |
| Håkanson, R | 1 |
| Willems, G | 1 |
| Gossner, L | 1 |
| May, A | 1 |
| Stolte, M | 1 |
| Seitz, G | 1 |
| Hahn, EG | 1 |
| Ell, C | 1 |
| Haydek, JM | 1 |
| Pace, F | 1 |
| Bianchi Porro, G | 1 |
| Jaffe, PE | 1 |
| Bhattacharyya, A | 1 |
| Sampliner, RE | 1 |
| Wetscher, GJ | 1 |
| Hinder, RA | 1 |
| Smyrk, T | 1 |
| Perdikis, G | 1 |
| Adrian, TE | 1 |
| Profanter, C | 1 |
| Van Laethem, JL | 1 |
| Peny, MO | 1 |
| Salmon, I | 1 |
| Cremer, M | 1 |
| Devière, J | 1 |
| Adamsson, I | 1 |
| Edlund, C | 1 |
| Nord, CE | 1 |
| Sauer, J | 1 |
| Junginger, T | 1 |
| Kahrilas, PJ | 1 |
| Falk, GW | 1 |
| Moore, KH | 1 |
| Barry, P | 1 |
| Burn, J | 1 |
| Falk, G | 1 |
| Keto, Y | 1 |
| Ebata, M | 1 |
| Okabe, S | 1 |
| Graffner, H | 1 |
| Singh, G | 1 |
| Chaudry, I | 1 |
| Milsom, JW | 1 |
| Bonfils, SJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluating Efficacy and Safety of Combined Thread Embedding and Auricular Acupuncture in Gastroesophageal Reflux Disease With Liver Qi Invading Stomach Pattern: A Randomized Controlled Trial[NCT06157424] | 66 participants (Anticipated) | Interventional | 2023-12-06 | Recruiting | |||
| Evaluation of MicroRNA Expression in Blood and Cytology Specimens as a Novel Method for Detecting Barrett's Esophagus[NCT02464930] | 220 participants (Anticipated) | Observational | 2015-04-30 | Recruiting | |||
| Endoscopic Resection or Ablation for Patients With Dysplasia or Intramucosal Cancer in Barrett's Esophagus[NCT01572987] | 12 participants (Actual) | Interventional | 2011-09-30 | Terminated (stopped due to Recruitment goals not being met) | |||
| Evaluation of Performance Characteristics of Capsule Endoscopy With PillCam UGI Capsule Compared to Standard Endoscopy for Screening of Barrett's Esophagus: A Prospective Tandem Study[NCT03167970] | 21 participants (Actual) | Observational | 2017-05-03 | Completed | |||
| A Phase II, Multi-Center Study of Interventional Spray Cryotherapy for Early-Stage Esophageal Cancer (ICE-CANCER)[NCT01868139] | 1 participants (Actual) | Interventional | 2013-06-30 | Terminated (stopped due to insufficient accrual) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
17 reviews available for omeprazole and Adenocarcinoma
| Article | Year |
|---|---|
Gastroesophageal Reflux Disease: A Review.
Topics: Adenocarcinoma; Barrett Esophagus; Diagnosis, Differential; Esophageal Neoplasms; Fundoplication; Ga | 2020 |
Clinical practice. Barrett's esophagus.
Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E | 2009 |
Clinical practice. Barrett's esophagus.
Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E | 2009 |
Clinical practice. Barrett's esophagus.
Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E | 2009 |
Clinical practice. Barrett's esophagus.
Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E | 2009 |
Clinical practice. Barrett's esophagus.
Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E | 2009 |
Clinical practice. Barrett's esophagus.
Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E | 2009 |
Clinical practice. Barrett's esophagus.
Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E | 2009 |
Clinical practice. Barrett's esophagus.
Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E | 2009 |
Clinical practice. Barrett's esophagus.
Topics: Adenocarcinoma; Algorithms; Barrett Esophagus; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; E | 2009 |
Does antireflux surgery prevent progression of Barrett's esophagus?
Topics: Adenocarcinoma; Barrett Esophagus; Cohort Studies; Combined Modality Therapy; Disease Progression; E | 2011 |
Do proton pump inhibitors protect against cancer progression in GERD?
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Barrett Esop | 2013 |
Reflux disease and Barrett's esophagus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Anti-Ulcer Agents; Barrett Esophagus; Endos | 2003 |
Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Amoxicillin; Clarithromycin; Drug The | 2003 |
Review article: test and treat or treat and test in reflux disease?
Topics: Adenocarcinoma; Ambulatory Care; Anti-Ulcer Agents; Barrett Esophagus; Esophageal Neoplasms; Gastroe | 2003 |
[The clinical strategy for the Barrett's esophagus].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Ba | 2005 |
Review article: putting immediate-release proton-pump inhibitors into clinical practice--improving nocturnal acid control and avoiding the possible complications of excessive acid exposure.
Topics: Adenocarcinoma; Barrett Esophagus; Chronotherapy; Delayed-Action Preparations; Disease Progression; | 2005 |
Barrett's esophagus: new definitions and approaches in children.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Barrett Esophagus; Child; Child, Preschool; Cimetidine; End | 1993 |
Gastro-oesophageal reflux and Helicobacter pylori.
Topics: Adenocarcinoma; Anti-Ulcer Agents; Barrett Esophagus; Diagnosis, Differential; Esophageal Neoplasms; | 1998 |
Microbial ecology and treatment of Helicobacter pylori infections: review.
Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; | 2000 |
[Conservative and surgical antireflux therapy as prevention of carcinoma].
Topics: Adenocarcinoma; Anti-Ulcer Agents; Barrett Esophagus; Biopsy; Clinical Trials as Topic; Esophageal N | 2000 |
Management of GERD: medical versus surgical.
Topics: Adenocarcinoma; Anti-Ulcer Agents; Costs and Cost Analysis; Esophageal Neoplasms; Esophagitis, Pepti | 2001 |
Gastroesophageal reflux disease and Barrett's esophagus.
Topics: Adenocarcinoma; Barrett Esophagus; Endoscopy, Gastrointestinal; Esophageal Neoplasms; Esophagus; Gas | 2001 |
[Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils].
Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer | 2001 |
[From acid secretion inhibition to enterochromaffin-like cell proliferation. Traps on the path].
Topics: Adenocarcinoma; Carcinoid Tumor; Enterochromaffin Cells; Gastric Mucosa; Gastrins; Gastritis, Atroph | 1991 |
7 trials available for omeprazole and Adenocarcinoma
| Article | Year |
|---|---|
Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
Topics: Adenocarcinoma; Adenoma; Aged; Aged, 80 and over; Analysis of Variance; Famotidine; Female; Gastric | 2012 |
Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.
Topics: Adenocarcinoma; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; | 2002 |
Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Child; Esophageal Neo | 2003 |
Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial.
Topics: Adenocarcinoma; Adult; Anti-Ulcer Agents; Double-Blind Method; Female; Gastritis; Helicobacter Infec | 2004 |
Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.
Topics: Adenocarcinoma; Aged; Anti-Ulcer Agents; Barrett Esophagus; Biopsy; Combined Modality Therapy; Dihem | 2007 |
Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cell Mo | 2008 |
KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barrett Esophagus; Esophageal Neo | 1999 |
38 other studies available for omeprazole and Adenocarcinoma
| Article | Year |
|---|---|
Laparoscopic total fundoplication is superior to medical treatment for reducing the cancer risk in Barrett's esophagus: a long-term analysis.
Topics: Adenocarcinoma; Barrett Esophagus; Esophageal Neoplasms; Fundoplication; Humans; Laparoscopy; Omepra | 2022 |
Omeprazole and adenocarcinoma in the stomach of rats submitted to duodenogastric reflux. Is there a protective effect?
Topics: Adenocarcinoma; Animals; Duodenogastric Reflux; Gastric Mucosa; Humans; Omeprazole; Proton Pump Inhi | 2020 |
Recent Developments Pertaining to H. pylori Infection.
Topics: Adenocarcinoma; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistan | 2021 |
Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat.
Topics: Adenocarcinoma; Adenoma; Animals; Azoxymethane; Carcinogens; Colonic Neoplasms; Omeprazole; Proton P | 2021 |
Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
Topics: Adenocarcinoma; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Barrett Esophagus; Case-Contro | 2018 |
Omeprazole prevents CDX2 and SOX9 expression by inhibiting hedgehog signaling in Barrett's esophagus cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Barrett Esophagus; CDX2 Transcription Factor; Cell Line, Tumo | 2019 |
Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study.
Topics: Adenocarcinoma; Adenoma; Aged; Anti-Ulcer Agents; Female; Gastric Mucosa; Gastroscopy; Humans; Male; | 2015 |
Deletion of
Topics: Adenocarcinoma; Adult; Animals; Benzodiazepines; Carcinogenesis; Carcinoid Tumor; Cell Line, Tumor; | 2017 |
Effect of alpha-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model.
Topics: Acetylcysteine; Adenocarcinoma; alpha-Tocopherol; Animals; Disease Models, Animal; Esophageal Neopla | 2009 |
Gastroesophageal reflux leads to esophageal cancer in a surgical model with mice.
Topics: Adenocarcinoma; Animals; Anti-Ulcer Agents; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibi | 2009 |
"War and Peace" with Barrett's esophagus.
Topics: Adenocarcinoma; Aged; Anti-Ulcer Agents; Antihypertensive Agents; Aspirin; Barrett Esophagus; Celeco | 2011 |
Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence.
Topics: Adenocarcinoma; Adenoma; Animals; Colonic Neoplasms; Computer Systems; Enzyme Inhibitors; Female; Fi | 2002 |
Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer.
Topics: Adenocarcinoma; Anti-Ulcer Agents; Barrett Esophagus; Catheter Ablation; Esophageal Neoplasms; Esoph | 2003 |
Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression?
Topics: Adenocarcinoma; Anti-Ulcer Agents; Barrett Esophagus; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; | 2002 |
Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barrett Esophagus; Esophageal Neo | 2003 |
Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Amoxicillin; Anti-Bacterial Agents; A | 2004 |
Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Administration, Oral; Animals; Duodenogastr | 2004 |
Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus.
Topics: Adenocarcinoma; Adult; Aged; Anti-Ulcer Agents; Aspirin; Barrett Esophagus; Cost-Benefit Analysis; D | 2004 |
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Animals; Antineoplastic Agents; Benzimidazo | 2004 |
[Disappearance of gastric adenocarcinoma in hyperplastic polyp after eradication of Heliobacter pylori. Report of a case].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combin | 2005 |
Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Barrett Eso | 2006 |
[Toxic epidermal necrolysis induced by phenytoin and whole brain radiotherapy].
Topics: Adenocarcinoma; Aged; Anticonvulsants; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; | 2007 |
Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer.
Topics: Adenocarcinoma; Aged; Anti-Ulcer Agents; Antineoplastic Agents; Barrett Esophagus; Biopsy; Esophagea | 1995 |
[Partial regression of Barret esophagus with high grade dysplasia and adenocarcinoma after photocoagulation and endocurietherapy under antisecretory treatment].
Topics: Adenocarcinoma; Barrett Esophagus; Brachytherapy; Combined Modality Therapy; Endoscopy, Digestive Sy | 1995 |
Omeprazole tolerability.
Topics: Adenocarcinoma; Animals; Humans; Neuroendocrine Tumors; Omeprazole; Rats; Stomach Neoplasms | 1994 |
Esophageal adenocarcinoma associated with Barrett's esophagus: long-term management with laser ablation.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Barrett Esophagus; Endoscopy; Esophageal Neoplasms; Esophag | 1995 |
Photodynamic therapy for Barrett's esophagus: clinical update.
Topics: Adenocarcinoma; Adenoma, Villous; Anti-Ulcer Agents; Barrett Esophagus; Biopsy; Esophageal Neoplasms | 1996 |
[Successful eradication of H. pylori in an elderly patient with gastric cancer after effective UFT-E therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adenocarcinoma; Aged; Aged, 80 and over; Anti-Ba | 1997 |
Brush cytology in the diagnosis of neoplasia in Barrett's esophagus.
Topics: Adenocarcinoma; Anti-Ulcer Agents; Barrett Esophagus; Biopsy; Cell Count; Cell Nucleus; Chromatin; C | 1997 |
The response of early gastric cancer to proton-pump inhibitors.
Topics: Adenocarcinoma; Adult; Aged; Diagnostic Errors; Female; Humans; Omeprazole; Proton Pump Inhibitors; | 1998 |
Endogenous hypergastrinaemia does not promote growth of colonic mucosa or of a transplanted colon adenocarcinoma in rats.
Topics: Adenocarcinoma; Animals; Cell Division; Colon; Colonic Neoplasms; Enzyme Inhibitors; Gastrins; Intes | 1998 |
Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Antineoplastic Agents; Barrett Es | 1999 |
Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up.
Topics: Adenocarcinoma; Aged; Anti-Ulcer Agents; Barrett Esophagus; Electrocoagulation; Esophageal Neoplasms | 1999 |
Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux.
Topics: Adenocarcinoma; Animals; Anti-Ulcer Agents; Disease Models, Animal; Duodenogastric Reflux; Esophagea | 1999 |
Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus.
Topics: Adenocarcinoma; Aged; Anti-Ulcer Agents; Barrett Esophagus; Esophageal Neoplasms; Esophagus; Humans; | 2000 |
Adenocarcinoma of the rat esophagus in the presence of a proton pump inhibitor: a pilot study.
Topics: Adenocarcinoma; Animals; Disease Models, Animal; Esophageal Neoplasms; Esophagostomy; Gastroesophage | 2001 |
Omeprazole-induced hypergastrinemia does not influence growth of colon carcinoma.
Topics: Adenocarcinoma; Animals; Cell Division; Colonic Neoplasms; Gastrins; Liver Neoplasms; Mice; Mice, In | 1992 |
Omeprazole.
Topics: Adenocarcinoma; Adult; Aged; Animals; Esophagitis, Peptic; Humans; Omeprazole; Rats; Stomach Neoplas | 1987 |